Background
Despite remarkable progress in the improvement of child survival between 1990 and 2015, the Millennium Development Goal (MDG) 4 target of a two-thirds reduction of under-5 mortality rate...
The World Malaria Report 2016 summarizes information received from malaria-endemic countries and other sources, and updates the analyses presented in the 2015 report.
The World Malaria Report is...
Following the decision to leave the EU, the UK will be even more engaged internationally. The multilateral system is vital to the UK and global interests and we will continue to be a committed...
The World Health Organization’s Regional Offices for Africa and for the Eastern Mediterranean in conjunction with the African Union and the Government of Ethiopia hosted a ministerial conference on...
Background
Despite the existence of effective prevention and treatment interventions, hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO aspires to global...
The 2016 Pneumonia and Diarrhea Progress Report: Reaching Goals Through Action and Innovation is the seventh annual Progress Report, but the first in the era of the Sustainable Development Goals...
The following report displays data and figures on the introduction status of pneumococcal conjugate vaccine (PCV), rotavirus vaccine, and inactivated polio vaccine (IPV) both globally and in 73 Gavi...
he Global Vaccine Action Plan (GVAP) ― endorsed by the 194 Member States of the World Health Assembly in May 2012 ― is a framework to prevent millions of deaths by 2020 through more equitable...
Nearly all of the 500,000 new cases of cervical cancer and 270,000 deaths occur in middle or lower income countries. Yet the two most prevalent HPV vaccines are unaffordable to most. Even prices to...
Attached is a new flyer that lists all the online courses available as part of the Immunization eLearning Initiative. This digital learning program was developed by WHO and UNICEF...
The Strategic Advisory Group of Experts (SAGE) on immunization met on 18-20 October
2016 in Geneva, Switzerland. At the mid-term of the Decade of Vaccines (DoV), SAGE reviewed the progress made...
The laboratory has always played a very critical role in diagnosis of the diseases. The success of any disease programme is based on a functional laboratory network. Health laboratory services are an...
Bull City Learning, World Health Organization (WHO), UNICEF
A case study has been published to share information about some of the change management and motivational strategies deployed by UNICEF and WHO to support high levels of participation in the...
Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015)...
Since 2011, a five-year strategy has guided Gavi’s mission to save children’s lives and protect people’s health by increasing access to immunisation. In this edition of its Annual Progress...
The 2010 TechNet21 Consultation was held in Kuala Lumpur from 30 November to 2 December 2010. This meeting provided “an opportunity for us (the participants) to join forces and define the VISION...
The Technet meeting was held from 26-27 October 2006 in Mexico city. Over 120 participants attended the conference. This report summarises the discussions.
The Antalya 2004 consultation, organized back-to-back with the Technology and Operations Panel meeting, welcomed a total of 105 participants including 15 participants representing national...
Technet was relaunched at the 2001 conference as Technet21. The New Delhi 2001 meeting, organized back-to-back with SIGN, welcomed a total of 107 participants including 23 participants representing...
The 1999 Technet consultative meeting was held in Harare, Zimbabwe, from 6 to 10 December 1999. Approximately 80 participants attended, representing global organizations, nongovernmental...
The 1998 Technet consultation was held at the WHO Regional Office for Europe, Copenhagen from 16 to 20 March 1998. This consultation gathered a wide range of experts and partners active in...
This report summarises the presentations and discussions that took place at the fifth Technet Conference that was held in Washington from 31 May to 4 June 1994.
This report sums up the discussions around EPI, logistics, cold chain and related issues at the Technet Conference held from 12-16 March 1990 in Nicosia, Cyprus.
Few countries in Africa currently include rubella-containing vaccination (RCV) in their immunization schedule. The Global Alliance for Vaccines Initiative (GAVI) recently opened a funding window that...
This is the first WHO position paper on a dengue vaccine. It focuses primarily on the available evidence concerning the only dengue vaccine to have been registered by National Regulatory Authorities...
Viral hepatitis is a serious health problem all over the world. However, the reduction of the morbidity and mortality due to vaccinations against hepatitis A and hepatitis B has been a major...
Summary
Background
With recent improvements in vaccines and treatments against viral hepatitis, an improved understanding of the burden of viral hepatitis is needed to inform global intervention...
Institute for Health Metrics and Evaluation and the International Centre for Humanitarian Affairs
The effort towards improving the health of the population in Kenya continues to produce results driven by accurate and timely data. Over the past three decades, the country has witnessed impressive...
The Global Polio Eradication Initiative is on the brink of a major milestone. As of April, 2016, the serotype 2 component of oral poliovirus vaccine (OPV) will be removed from all immunisation...
WHO has published global guidance for immunization managers and maternal child health
professionals seeking to introduce hepatitis B birth dose into national immunization programmes
or to...
Each year, UNICEF’s flagship publication, The State of the World\'s Children, closely examines a key issue affecting children. The report includes supporting data and statistics and is available in...
The global incidence of JE is unknown because the intensity and quality of JE surveillance and the availability of diagnostic laboratory testing vary throughout the world. Countries that have...
The Developing Countries Vaccine Manufacturers Network (DCVMN) assembled high-profile leaders from global health organisations and vaccine manufactures for its 16th Annual General Meeting to work...
Zika virus was originally identified in a sentinel rhesus monkey in the Zika Forest of Uganda in 1947. The virus is a member of the family Flaviviridae, genus Flavivirus, and is transmitted to humans...
The overall goal of this Toolkit is to support countries in the reactivation of essential health services in the aftermath of a public health emergency. The Toolkit has been constructed to support...
Lauded for getting specific health issues onto national and international agendas and for their potential to improve value for money and outcomes, public-private global health initiatives (GHIs) have...
An infectious disease will be eradicated only if it is eliminated everywhere, including in the hardest-to-reach, most vaccine-wary communities. If eradication is successful, it promises a dividend in...
Ane B. Fisker, Linda Hornshøj, Amabelia Rodrigues, Ibraima Balde, Manuel Fernandes, Christine S. Benn, Peter Aaby
In 2008, the GAVI Alliance funded the introduction of new vaccines (including pentavalent diphtheria-tetanus-pertussis [DTP] plus hepatitis B and Haemophilus influenzae type b antigens) in...
As of 11 May 2016, 58 countries and territories report continuing mosquito-borne transmission (Fig. 1) of which: 45 countries are experiencing a first outbreak of Zika virus since 2015, with...
GAVI’s focus on reducing inequities in access to vaccines, immunization, and GAVI funds, − both between and within countries - has changed over time. This paper charts that evolution.
Since the 1915 launch of the first international eradication initiative targeting a human pathogen, much has been learned about the determinants of eradicability of an organism. The authors outline...
In May 2015, the World Health Assembly endorsed a new Global Technical Strategy for Malaria. The strategy includes ambitious goals for malaria control and elimination in the next 15-year period. A...
n the past several years, as worldwide morbidity and mortality due to malaria have continued to decrease, the global malaria community has grown increasingly supportive of the idea of malaria...
Advocacy, policy, research and intervention efforts against childhood pneumonia have lagged behind other health issues, including malaria, measles and tuberculosis. Accelerating progress on the issue...
This evaluation assesses the extent to which the Advanced Market Commitment (AMC) pilot has achieved its stated objectives and the overarching goal to “reduce morbidity and mortality from...
This decision-framework document aims to provide an approach for deciding which vaccines, if pre-emptively and properly delivered at the outset of an emergency, would constitute high priority...
The purpose of GRISP is to reassert routine immunization as the foundation for sustained decreases in morbidity and mortality from vaccine-preventable diseases across the life-cycle of all...
In a recent study on ethics in humanitarian health care, respondents pointed out the need for ethical guidance on issues such as vaccination during emergency situations.3 The World Health...
This report presents the findings of the Outcomes and Impact evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2015 by The Boston...
Middle-income countries (MICs) as a group are not only characterized by a wide range of gross national income (GNI) per capita (US $1026 to $12,475), but also by diversity in size, geography,...
The fourteenth TechNet Conference was held in Bangkok, Thailand from 11 to 15 May, 2015. Two hundred and fifty six delegates attended the conference. The theme of the conference was “Immunization...
To provide updates for the 2015 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines on human papillomavirus (HPV) and anogenital warts (AGWs), a review of...
No confirmed cases of Ebola virus disease (EVD) were reported in the week to 27 December. On 29 December, WHO declared that human-to-human transmission of Ebola virus has ended in Guinea, after...
This paper—designed for use by US executive branch officials, members of Congress, advocates, and other stakeholders— presents an analysis of the USG’s role in global immunization and offers...
In support of accelerated development of Ebola vaccines from preclinical research to clinical trials, in November, 2014, the Wellcome Trust and the Center for Infectious Disease Research and Policy...
The west African Ebola epidemic that began in 2013 exposed deep inadequacies in the national and international institutions responsible for protecting the public from the far-reaching human, social,...
This 2015 Pneumonia and Diarrhea Progress Report evaluates the progress of the 15 countries with the greatest burden of under-five pneumonia and diarrhea
deaths in implementing high-impact...
Sensitivity analysis suggests that the finding of positive net benefits of the GPEI remains robust over a wide range of assumptions, and that consideration of the additional net benefits of...
The thirteenth TechNet Conference was held in Dakar, Senegal, from 5 to 7 February, 2013. One hundred and ninety-one delegates attended the conference. The sessions were broadly categorised under six...
In 2011, the story of immunisation coverage worldwide hovers between the glass half empty and the glass half full. Anticipated advances in vaccinology during this new Decade of Vaccines will only...
In mid-April of 1958 the Government of Pakistan summoned the press to announce a grave need for international aid to cope with smallpox and cholera epidemics in East Pakistan. In response, and with...
Bioterrorism is the deliberate release of biological toxins, pathogenic viruses, bacteria, parasites, or other infectious agents into the public sphere with the objective of causing panic, illness,...
In 2011, the World Health Organization will recommend the fate of existing smallpox stockpiles, but circumstances have changed since the complete destruction of these cultures was first proposed....
The growing demand for reliable data to monitor progress in health has highlighted the need to strengthen the way estimates for health indicators are generated.
Global health estimation work should...
The United Nations Millennium Development Goals are approaching their deadline of 2015 but progress to date has been insufficient. Public expenditure on health – both domestic and official...
As health intervention, vaccination has had a tremendous impact on reducing mortality and morbidity caused by infectious diseases. Traditionally vaccines were developed and made in the western,...
Over the past several years, the development of new vaccines, along with global efforts to make them more available and affordable, has resulted in the introduction of lifesaving vaccines in...
The study concludes that there is a persistent insufficiency in drug and vaccine development for neglected diseases. Nevertheless, these and other data show a slight improvement during the past 12...
On the 20th anniversary of the 1993 World Development Report (WDR),1 the report of the Lancet Commission on Investing in Health reaffirms that investing in health is a strategic investment with...
Emerging and re-emerging infectious disease (EID) events can have devastating human, animal and environmental health impacts. The emergence of EIDs has been associated with interconnected economic,...
The Ebola epidemic will take hundreds of thousands of lives if the current trajectory is not reversed.1 Fear has gripped the most affected countries: Sierra Leone instituted a national lockdown,2...
In response to the spread of Ebola virus disease in west Africa, global public health agencies have scrambled to organise teams to staunch the spiral of infections and have urged researchers in...
In this article, the researcher examines the level and speed of the international donations to tackle the Ebola epidemic and how they aligned with evolving estimates of funds required to bring the...
We live in a remarkable era of accelerated progress in reducing child deaths in the poorest countries.1 The death rate in children younger than 5 years in low-income countries has dropped by 28·1%...
In 1988, the World Health Assembly of the World Health Organization (WHO) resolved to eradicate polio worldwide. Among the three wild poliovirus (WPV) types (type 1, type 2, and type 3), WPV type 2...
This eleventh edition of Progress for Children is UNICEF’s final report on the child-related Millennium Development Goals (MDGs). It presents latest data that show while the MDGs helped drive...
The study concludes that global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health...
As countries prepare to introduce IPV, there is an opportunity to leverage lessons learned from countries that have already introduced the vaccine. The purpose of this document is to give an in-depth...
Dean Jamison, Prabhat Jha, Ramanan Laxminarayan, and Toby Ord identify five top priorities in the fight against infectious disease. The most important of these is malaria treatment. There is a rapid...
Since the early days of EPI in the late 1970’s there has been a need for specialised cold chain equipment designed to meet the demanding performance requirements of the developing world, where fuel...
Conference Guide for the 14th TechNet Conference, which was held in Bangkok, Thailand between May 11-15, 2015. The theme of the conference was: \"Immunization Supply Chain and Logistics:Current...
The Independent Monitoring Board provides an independent assessment of the progress being made by the Global Polio Eradication Initiative in the detection and interruption of polio transmission...
In 1988, the World Health Assembly (WHA) resolved to eradicate polio worldwide. In 2015, only Afghanistan and Pakistan have reported wild poliovirus (WPV) transmission. Timely steps are needed for...
From 3-4 March 2015, over 130 members from 70 countries – representing all six regions of the world1 – gathered in Istanbul, Turkey for the Inaugural Conference of the International Association...
This article examines the multifaceted structures and complex operations of the World Health Organization and its regional offices; it also reassesses the form and the workings of the global smallpox...
The Global Immunization Meeting: Protect, Innovate, Accelerate was organized jointly by WHO and UNICEF and served as forum to update the global immunization community on implementing the new...
Reimagining Global Health (2.7 MB PDF), the inaugural report of the PATH-led Innovation Countdown 2030 initiative, features 30 high-impact innovations to save lives and expert commentaries on the...
Le Plan d\'action mondial pour les vaccins ( GVAP ) - approuvée par les 194 États membres de l\'Assemblée mondiale de la Santé en mai 2012 - est un cadre pour prévenir des millions de décès...
Plan de Acción Mundial sobre Vacunas ( GVAP ) - aprobada por los 194 Estados miembros de la Asamblea Mundial de la Salud en mayo de 2012 - es un marco para evitar la prevención de muertes millón...
Un esquema integral de la Inmunización Visión y Estrategia Mundial para el período 2006-2015 , qui tiene como objetivo mantener los niveles existentes de cobertura de la vacuna , extender los...
In May 2011, a report by the Secretariat on the global immunization
vision and strategy was noted by the Sixty-fourth World Health
Assembly (WHA)/ During the discussions the vision for the...